Skip to main content

Predictmedix Secures Strategic Partnership with Entertainment Bay India LLP, a Tier-1 Indian Event Production Company

Safe Entry Stations to Address the Significant Live Event Market in India

TORONTO, ON / ACCESSWIRE / October 5, 2021 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company"), a leading provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that it has secured a new strategic partnership with Entertainment Bay, India LLP, one of the largest event production companies in India, for the deployment of Safe Entry Stations at its client events.

Entertainment Bay is a leading event production company in India, leveraging 10+ years of experience providing a full range of event management services for companies, organizations and individuals at stadiums, theaters, music venues, hotels and conference event centers.

Under the terms of the partnership agreement, Predictmedix will deploy Safe Entry Stations at select Entertainment Bay hosted events to rapidly identify multiple symptoms of infectious diseases such as COVID-19. Predictmedix expects to realize a pricing structure of approximately $1,000 per unit per day or as the budget of the respective event permits.

"Our strategic partnership with Entertainment Bay marks our head-first deployment into the significant Indian live-event space," said Dr. Rahul Kushwah, Chief Operating Officer at Predictmedix. "Each year Entertainment Bay manages over 100 events, giving us the potential to scale rapidly into its large portfolio of customers. We look forward to working closely with their team to deploy Safe Entry stations at a variety of large- and small-scale events throughout India, creating a safer environment for attendees."

Zain Rais, Founder of Entertainment Bay added, "Our commitment is to providing unforgettable experiences for our clients in a safe and secure environment. Given the increasing urgency to provide advanced health safety protocols, we believe Predictmedix provides the best possible screening technology given it operates in an autonomous and time-efficient fashion with a high level of accuracy."

About Entertainment Bay

Entertainment Bay is a leading event production company in India with over 10 years' experience providing a full range of event services and management for companies, organizations and individuals at stadiums, theaters, music venues, hotels and conference event centers. For more information visit

About Predictmedix Inc.

Predictmedix (CSE:PMED) (OTCQB:PMEDF) is a leading provider of rapid health screening and remote patient care solutions globally. The Company's Safe Entry Stations - powered by a proprietary artificial intelligence (AI) - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, or various mental illnesses. Predictmedix's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at or follow us on Twitter, Instagram or LinkedIn.

Investor Relations Contact
Lucas A. Zimmerman
MZ Group - MZ North America

Caution Regarding Forward-Looking Information:


This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company's securities have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulations under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein, such as, but not limited to dependence on obtaining regulatory approvals; the ability to obtain intellectual property rights related to its technology; limited operating history; general business, economic, competitive, political, regulatory and social uncertainties, and in particular, uncertainties related to COVID-19; risks related to factors beyond the control of the company, including risks related to COVID-19; risks related to the Company's shares, including price volatility due to events that may or may not be within such party's control; reliance on management; and the emergency of additional competitors in the industry.

All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except required by law.

Disclaimer: "The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time."

SOURCE: Predictmedix

View source version on

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.